Allergan's most recent trend suggests a bullish bias. One trading opportunity on Allergan is a Bull Put Spread using a strike $130.00 short put and a strike $120.00 long put offers a potential 8.7% return on risk over the next 24 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $130.00 by expiration. The full premium credit of $0.80 would be kept by the premium seller. The risk of $9.20 would be incurred if the stock dropped below the $120.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Allergan is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Allergan is bullish.
The RSI indicator is at 23.67 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Allergan
CLASS ACTION UPDATE for DNKEY, YOGA, AGN and MHLD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Sun, 17 Feb 2019 22:00:00 +0000
NEW YORK, Feb. 17, 2019 — Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies..
FILING DEADLINE–Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of XRAY, AGN, ALKS and SVXY
Sun, 17 Feb 2019 16:00:00 +0000
The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are encouraged to contact the firm regarding possible appointment as lead plaintiff and a preliminary estimate of their recoverable losses. If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court.
CLASS ACTION UPDATE for XRAY, NVDA, AGN and YRIV: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Sun, 17 Feb 2019 12:12:00 +0000
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided.
ALLERGAN 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess Of $100,000 of Deadline in Class Action Lawsuit Against Allergan plc. – AGN
Sat, 16 Feb 2019 03:50:00 +0000
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with large financial interests that they have only until February 19, 2019 to file lead plaintiff applications in a securities class action lawsuit against Allergan plc. (AGN). Investor losses must relate to purchases of the Company’s shares between February 24, 2017, and December 19, 2018.
Allergan PLC (AGN) Files 10-K for the Fiscal Year Ended on December 31, 2018
Fri, 15 Feb 2019 22:48:32 +0000
Allergan PLC is a specialty pharmaceutical company engaged in the development, manufacturing, marketing, and distribution of brand name pharmaceutical products, medical aesthetics, biosimilar and OTC pharmaceutical products. The dividend yield of Allergan PLC stocks is 2.09%. Warning! GuruFocus has detected 2 Warning Sign with AGN.
Also on Market Tamer…
Follow Us on Facebook